Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient

American Journal of the Medical Sciences

Volumn 332, Issue 6, 2006, Pages 364-367

  Chan Tack, Kirk M ^a,b   Ahuja, Navneet ^b   Weinman, Edward J ^b   Wali, Ravinder K ^b   Uche, Anayochukwu ^a,b   Greisman, Lisa A ^a,b   Drachenberg, Cinthia ^b   Hawkins, Philip N ^c   Redfield, Robert R ^a,b,d,e,f  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d ABBOTT LABORATORIES   (United States)

^e Abbott ^*  (Germany)

^f GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Amyloidosis; HIV; Nephrotic syndrome; Proteinuria; Renal failure

Indexed keywords

ABACAVIR; AMYLOID A PROTEIN; ATAZANAVIR; CONGO RED; COTRIMOXAZOLE; DIAMORPHINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE; RITONAVIR; TENOFOVIR;

ACUTE KIDNEY FAILURE; ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; NEPHROSIS; NONHUMAN; PATHOLOGY; PROTEINURIA;

ADULT; AMYLOIDOSIS; ANTI-HIV AGENTS; FATAL OUTCOME; HIV INFECTIONS; HUMANS; KIDNEY FAILURE, ACUTE; MALE; NEPHROSIS;

EID: 33845781992     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200612000-00012     Document Type: Article

References (25)

1. Joseph A, Wali RK, Weinman EJ. Renal amyloidosis in AIDS. Ann Intern Med 2000;133:75.
2. Berggren R, Batuman V. HIV-associated renal disorders: recent insights into pathogenesis and treatment. Curr HIV/AIDS Rep 2005;2:109-15.
3. Atta MG, Choi MJ, Longenecker JC, et al. Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy. Am J Med 2005;118:1288.e21-1288.e26.
4. Lanjewar DN, Ansari MA, Shetty CR, et al. Renal lesions associated with AIDS-an autopsy study. Ind J Pathol Microbiol 1999;42:63-8.
5. Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004;66:1145-52.
6. Szczech LA, Kalayjian R, Rodriguez R, et al. The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis. The Adult Aids Clinical Trial Group Renal Complications Committee. Kidney Int 2003;63:2295-301.
7. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999;55:1036-40.
8. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005;40:1559-85.
9. Zimmermann AE, Pizzoferrato T, Bedford J, et al. Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Clin Infect Dis 2006;42:283-90.
10. Richards NT, Darby S, Howie AJ, et al. Knowledge of renal histology alters patient management in over 40% of cases. Nephrol Dial Transplant 1994;9:1255-9.
11. Cozzi PJ, Abu-Jawdeh GM, Green RM, et al. Amyloidosis in association with human immunodeficiency virus infection. Clin Infect Dis 1992;14:189-91.
12. Osick LA, Lee TP, Pedemonte MB, et al. Hepatic amyloidosis in intravenous drug abusers and AIDS patients. J Hepatol 1993;19:79-84.
13. Tan AU Jr, Cohen AH, Levine BS. Renal amyloidosis in a drug abuser. J Am Soc Nephrol 1995;5:1653-8.
14. Martin Navarro J, Caramelo Diaz C, Marron B, et al. AA amyloidosis in an HIV-seropositive patient: case report and review of the literature. Rev Clin Esp 2003;203:51-3.
15. Menchel S, Cohen D, Gross E, et al. AA protein-related renal amyloidosis in drug addicts. Am J Pathol 1983;112:195-9.
16. Neugarten J, Gallo GR, Buxbaum J, et al. Amyloidosis in subcutaneous heroin abusers ('skin poppers' amyloidosis). Am J Med 1986;81:635-40.
17. Thompson B, Burns A, Davenport A. Recreational drug abuse in a dialysis patient. Nephrol Dial Transplant 2002;17:675-6.
18. Paiardini M, Cervasi B, Dunham R, et al. Cell-cycle dysregulation in the immunopathogenesis of AIDS. Immunol Res 2004;29:253-68.
19. Husebekk A, Permin H, Husby G. Serum amyloid protein A (SAA): an indicator of inflammation in AIDS and AIDS-related complex (ARC). Scand J Inf Dis 1986;18:389-94.
20. Buxbaum J. Amyloidosis, AA (Inflammatory). Available at: www.emedicine.com. Accessed January 10, 2006.
21. Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 1991;70:246-56.
22. Korkmaz C. Immunosuppressive treatment of AA amyloidosis of familial Mediterranean fever. Clin Exp Rheumatol 2005;23:S107-8.
23. Perez Equiza E, Arguinano JM, Gastearena J. Successful treatment of AA amyloidosis secondary to Hodgkin's disease with 4′-iodo-4′- deoxydoxorubicin. Haematologica 1999;84:93-4.
24. Gillmore JD, Lovat LB, Persey MR, et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24-9.
25. Nishikido M, Koga S, Kanetake H, et al. Renal transplantation in systemic amyloidosis. Clin Transplant 1999;13 Suppl 1:S63-6.